YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Treace Medical Concepts, Inc. (NASDAQ:TMCI) announced five-year ALIGN3D results on September 17, adding longer-term evidence for the Lapiplasty bunion-correction procedure. The final analysis included 137 of 173 treated patients, or approx…
Tandem Diabetes Care, Inc. TNDM shares rallied 7.7% in the last trading session to close at $17.53. This move can be attributable to notable volume with a higher number of shares being traded than in a typical session. This compares to the…
Treace Medical Concepts, Inc. New product offerings extend bunion market leadership and accelerate penetration into new foot & ankle market adjacencies PONTE VEDRA, Fla., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("T…
Treace Medical Concepts, Inc. Q2 2026 Earnings Call Summary - Moby Strategic Performance Drivers Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick.…
(RTTNews) - Today's top gainers include Boundless Bio, which is combining with privately held Serapha; Monopar, on track for an NDA submission of ALXN1840 for Wilson disease; Jade Biosciences, advancing its autoimmune disease pipeline; and…
NEW YORK, NY / ACCESS Newswire / June 16, 2026 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day June Small-Cap Virtual Investor Conference taking place Wednesd…
(RTTNews) - Today's top biotech gainers include Parabilis, following a strong debut on its first day of trading; Shoulder Innovations, which recently issued a rosy outlook for the year; and Clover Health, which won a legal victory in its d…
Image source: The Motley Fool. Date Thursday, February 26, 2026 at 4:30 p.m. ET Call participants Chief Executive Officer — John T. Treace Chief Financial Officer — Mark L. Hair Full Conference Call Transcript John Treace, Chief Executive…
Image source: The Motley Fool. DATE Friday, May 8, 2026 at 8 a.m. ET CALL PARTICIPANTS Chief Executive Officer — John Treace Chief Financial Officer — Mark Hair Full Conference Call Transcript John Treace, Chief Executive Officer; and Mark…
Treace Medical Concepts logo Key Points Interested in Treace Medical Concepts, Inc.? Here are five stocks we like better. Treace Medical Concepts reaffirmed its full-year 2026 revenue outlook of $202 million to $212 million, even after fir…
PONTE VEDRA, Fla., May 08, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfo…
Quant rankings for the upcoming earnings calendar show strength concentrated across information technology, energy, and materials, while weakness is more pronounced in health care, consumer-facing segments, and real estate. A total of 1468…
The United States market has shown robust performance, climbing 3.1% over the last week and 27% over the past year, with earnings projected to grow by 16% annually. In this context of market growth, identifying stocks with strong financial…
ArtivionAORT shares soared 5.3% in the last trading session to close at $35.22. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 7.3% loss over the past four wee…
PONTE VEDRA, Fla., April 07, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related mid…
Earnings Call Insights: Treace Medical Concepts (TMCI) Q4 2025 MANAGEMENT VIEW * John Treace, Founder, Chairman & CEO, highlighted that Treace Medical has transitioned into a comprehensive bunion solutions company in 2025, now capable of a…
UFP Technologies (UFPT) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.46 per share a year ago. These figures are adjusted for non-recurring ite…
UFP Technologies (UFPT) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.26 per share. This compares to earnings of $2.46 per share a year ago. These figures are adjusted for non-recurring ite…
PONTE VEDRA, Fla., Feb. 12, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midf…
We recently published an article titled 11 High Growth Micro-cap Stocks to Buy. Treace Medical Concepts is one of the high-growth micro-cap stocks to buy. On January 7, Stifel lowered its price target on Treace Medical Concepts, Inc. (NASD…
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether certain officers and directors of Quantum Computing Inc. (NASDAQ: QUBT), Quanex Building Products Corporation (NYSE: NX), Treace Medical Concepts, I…
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Treace Medical Concepts has seen its price target reset lower in recent research, even as the model fair value per shar…
PONTE VEDRA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midf…
The latest research on Treace Medical Concepts trims the modeled fair value only slightly, from US$5.47 to US$5.27, while nudging the discount rate and revenue growth assumptions to slightly more cautious levels. These fine tuning moves re…
PONTE VEDRA, Fla., Dec. 18, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midf…
(RTTNews) - The after-hours market delivered a mixed but generally positive tone on Tuesday evening, with several small- and mid-cap names posting modest gains. One biotech, however, stole the spotlight with a dramatic surge following majo…
The U.S. stock market has been experiencing mixed movements, with the Dow Jones Industrial Average recently setting a new all-time high while the Nasdaq and S&P 500 have pulled back due to concerns over tech stocks. Despite these fluctuati…
Treace Medical Concepts' latest narrative update has left the fair value estimate steady at roughly $5.47 per share, even as the discount rate has edged down from about 8.65% to 8.60% and revenue growth expectations hold near 2.10% a year.…
SAN DIEGO, Dec. 01, 2025 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating whether certain officers and directors of Quantum Computing Inc. (NASDAQ: QUBT), Quanex Building Products Corporation (NYSE: NX), Treace Medical Concepts, I…
Treace Medical Concepts has recently seen its consensus analyst price target decline sharply, dropping from $6.56 to $5.47 per share. This adjustment reflects less optimistic revenue growth projections and a slightly higher discount rate,…
Treace Medical Concepts has recently seen its consensus analyst price target cut from $8.58 to $6.56, reflecting a notable reduction in perceived fair value. While analyst notes highlight encouraging developments in product expansion and m…
PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midf…
PHILADELPHIA, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. (NAS…
PHILADELPHIA, Oct. 27, 2025 (GLOBE NEWSWIRE) -- Five Below, Inc. (NASDAQ: FIVE) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Five Below Inc. (NASDAQ: FIVE) as securities…
PONTE VEDRA, Fla., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midf…
PHILADELPHIA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) – Class Action Survives Motion to Dismiss: Grabar Law Office is investigating claims on behalf of shareholders of Amylyx Pharmaceuticals, Inc. (NAS…